NCT05027698View on ClinicalTrials.gov

Post-Market Clinical Investigation of the FemoSeal™ VCS: A Prospective, Multi-Center Observational European Study

CompletedOBSERVATIONAL

Enrollment

230

Participants

Timeline

Start Date

December 27, 2021

Primary Completion Date

July 4, 2022

Study Completion Date

August 3, 2022

Conditions

Vascular ClosureEndovascular ProcedureHemostasisPeripheral Vascular Disease

Trial Locations (3)

9200

AZ Sint Blasius, Dendermonde

75014

Hôpital Paris St Joseph, Vascular and endovascular surgical center, Paris

79189

Universitäts-Herzzentrum Freiburg Bad Krozingen, Department of Cardiology and Angiology Department, Bad Krozingen

All Listed Sponsors

lead

Terumo Europe N.V.

INDUSTRY

NCT05027698 - Post-Market Clinical Investigation of the FemoSeal™ VCS: A Prospective, Multi-Center Observational European Study | Biotech Hunter | Biotech Hunter